DRUG · Mapped RxNorm record
Exemestane
Normalized identity: exemestaneView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
NCT00073073
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DIETARY_SUPPLEMENT · Unmapped registry intervention
Calcium carbonate
Find medicine records ·
Find other trials using this name
DIETARY_SUPPLEMENT · Unmapped registry intervention
Vitamin D
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedExemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Neoplasmsunresolved
Interventions
ExemestaneDRUG · verified · RxNorm: exemestane
Calcium carbonateDIETARY_SUPPLEMENT
Vitamin DDIETARY_SUPPLEMENT
Sponsors & collaborators
Georgetown Universitylead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00073073 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.